Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can hepatic metabolic dysfunction contribute to low energy?

Hepatic metabolic dysfunction can contribute to low energy by impairing glucose availability, lipid-driven ATP production, and protein synthesis.

PlausibleJuly 9, 202643 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Hepatic metabolic dysfunction can contribute to low energy by disrupting glucose availability, lipid handling, and protein synthesis.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says the liver’s metabolic role is central to maintaining normal energy levels, so dysfunction can ripple into systemic fatigue. The mechanism framing shows this happening through reduced glucose output, impaired lipid oxidation and ATP generation, and lowered albumin production that can further weaken energy delivery and contribute to fatigue.

Verified conclusion

The liver is the central metabolic hub coordinating systemic energy balance. When hepatic metabolic pathways are compromised, energy deficits cascade throughout the body, manifesting as profound physical and cognitive fatigue.

Mechanistic pathways of hepatic fatigue

  • Disrupted Glucose Homeostasis: Hepatic metabolic dysfunction impairs crucial glycogenolysis and gluconeogenesis pathways. In conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), hepatic insulin resistance drives volatile glucose fluctuations, while impaired gluconeogenesis causes hypoglycemia. This deprives high-demand tissues, such as the brain and skeletal muscles, of their primary fuel source.
  • Mitochondrial & Lipid Dysfunction: Hepatic metabolic stress triggers an influx of free fatty acids and elevated de novo lipogenesis. The resulting accumulation of lipotoxic ceramides inhibits key beta-oxidation enzymes, including carnitine palmitoyltransferase-1 (CPT-1) and acyl-CoA synthetase long-chain family member 1 (ACSL1). This blocks mitochondrial beta-oxidation, depolarizes mitochondrial membranes, generates reactive oxygen species (ROS), and severely depletes cellular ATP.
  • Impaired Protein Synthesis: Because the liver is the exclusive site of albumin synthesis, hepatocyte dysfunction leads to hypoalbuminemia. This drives systemic fatigue by reducing plasma oncotic pressure (causing fluid shifts and muscle hypoperfusion), disrupting the transport of essential energy substrates, and increasing the plasma ratio of free tryptophan to branched-chain amino acids, which accelerates brain serotonin synthesis to trigger central fatigue.

Bottom line

  • Hepatic metabolic dysfunction directly causes low systemic energy by impairing glucose release, disrupting lipid-fueled mitochondrial ATP production via CPT-1 and ACSL1 inhibition, and suppressing albumin synthesis to drive central fatigue, tissue hypoperfusion, and muscle wasting.

References

  1. Biochemistry - Glycogenolysis - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  2. Regulation of glucose metabolism from a liver-centric perspective — nature.com ↗
  3. Physiology, Gluconeogenesis - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  4. Gluconeogenesis - an overview | ScienceDirect Topics — sciencedirect.com ↗
  5. Resolving the Paradox of Hepatic Insulin Resistance - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Hepatic selective insulin resistance at the intersection of ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  7. Increased liver glycogen levels enhance exercise capacity in mice — pmc.ncbi.nlm.nih.gov ↗
  8. Fundamentals of glycogen metabolism for coaches and athletes — academic.oup.com ↗
  9. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver ... — pmc.ncbi.nlm.nih.gov ↗
  10. Role of mitochondrial quality control in the pathogenesis ... - Aging-US — aging-us.com ↗
  11. Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty ... — pmc.ncbi.nlm.nih.gov ↗
  12. Nonalcoholic fatty liver disease: molecular mechanisms for ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  13. Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics ... — onlinelibrary.wiley.com ↗
  14. Mechanism of metabolic dysfunction-associated steatotic liver disease — eurekalert.org ↗
  15. Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population. — linkinghub.elsevier.com ↗
  16. Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes — jstage.jst.go.jp ↗
  17. Regulation of lipid stores and metabolism by lipophagy - Nature — nature.com ↗
  18. Developmental and metabolic toxicity of diphenyl phosphate: insights from an integrative mechanistic framework in zebrafish embryos. — linkinghub.elsevier.com ↗
  19. Fatty acid oxidation disorders - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  20. Clinical manifestations and management of fatty acid oxidation ... — pmc.ncbi.nlm.nih.gov ↗
  21. Mitochondria and CFS - ME Research UK — meresearch.org.uk ↗
  22. ME/CFS: Mitochondrial Dysfunction, Autoimmunity & Dysautonomia — franklincardiovascular.com ↗
  23. Physiology, Albumin - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  24. Hypoalbuminemia: Background, Pathophysiology, Etiology — emedicine.medscape.com ↗
  25. Albumin Synthesis : New England Journal of Medicine - Ovid — ovid.com ↗
  26. Evaluating Liver Test Abnormalities: Tests of Liver Function — hepatitis.va.gov ↗
  27. Liver function tests: indication and interpretation — pharmaceutical-journal.com ↗
  28. Low Albumin Levels: What it Reveals About Nutrition and Liver - Ubie — ubiehealth.com ↗
  29. Low Albumin? Why Your Body Is Losing Protein & Medically ... - Ubie — ubiehealth.com ↗
  30. Low albumin (Hypoalbuminemia): Symptoms and treatment — medicalnewstoday.com ↗
  31. Hypoalbuminemia: Causes, Symptoms, Treatment & Outlook — my.clevelandclinic.org ↗
  32. Low Albumin Symptoms You Shouldn't Ignore - Direct Care Labs — directcarelabs.com ↗
  33. Signs You're Not Getting Enough Protein - WebMD — webmd.com ↗
  34. Hypoalbuminemia - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  35. Hypoalbuminemia - Wikipedia — en.wikipedia.org ↗
  36. [PDF] Hypoalbuminemia and edema formation - Allied Academies — alliedacademies.org ↗
  37. Sarcopenia in Liver Disease - Medscape — medscape.com ↗
  38. Deciphering Sarcopenia - Consult QD — consultqd.clevelandclinic.org ↗
  39. Sarcopenia in chronic liver disease: mechanisms and ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  40. Role of oxidative stress in the pathogenesis of nonalcoholic fatty ... — sciencedirect.com ↗
  41. the Original Sin? The Recent Mitochondrial ME/CFS Studies — healthrising.org ↗
  42. Mitochondrial dysfunction in long COVID - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  43. Changes in the albumin binding of tryptophan during postoperative ... — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→